Patent · US Active

Methods of treating cancer in pediatric patients

US11529363B2 · kind B2 · utility

0Cited by
0References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2019
Grant dateDec 20, 2022
Priority date
Expiry dateJul 13, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for treating cancers (e.g., inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma) in pediatric patients using brigatinib, as monotherapy or combination therapy with one or more second therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.